Nippon India Mutual Fund has increased its shareholding in Sanofi Consumer Healthcare India Limited. Through open market purchases conducted between June 14, 2024, and April 29, 2026, the fund acquired an additional 30,000 equity shares. This latest transaction brings the total shareholding of Nippon India Mutual Fund to 11,62,073 shares, representing 5.0458% of the total paid-up equity capital of the company.
Shareholding Pattern Update
Nippon India Mutual Fund has updated its investment position in Sanofi Consumer Healthcare India Limited. Following a series of strategic acquisitions in the open market, the fund now holds a total of 11,62,073 equity shares. This position accounts for 5.0458% of the target company’s total voting capital, officially crossing the 5% threshold.
Details of the Acquisition
The accumulation of shares was executed through standard open market transactions over an extended period, starting from June 14, 2024, and concluding on April 29, 2026. The most recent purchase involved 30,000 shares, which solidified the fund’s position at the 5.0458% mark. Before these latest acquisitions, the fund held 11,32,073 shares, equivalent to 4.9155% of the company’s equity.
Corporate Capital Structure
As per the latest disclosure, the total equity capital of Sanofi Consumer Healthcare India Limited stands at Rs 23,03,06,220, comprising 2,30,30,622 shares with a face value of Rs 10 per share. The shareholding change reflects the continued investment interest of Nippon India Mutual Fund in the company’s growth trajectory.
Source: BSE
